OSCR

<i>Lactobacillus reuteri</i> DSM 17938 and Its Supernatant Ameliorate Parkinson's Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism.

Overview

Authors: Bin Su1,2, Fanying Meng1,2, Yao Lu1,2, Yunlong Zhang1,2, Tingting Wang1,2, Yuxin Zhang1,2, Jiajia Liu1,2, Lianbing Lin1,2
  1. Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China; (B.S.); (F.M.); (Y.L.); (Y.Z.); (T.W.); (Y.Z.); (J.L.)
  2. Engineering Research Center for Replacement Technology of Feed Antibiotics of Yunnan College, Kunming 650500, China
Journal: Antioxidants (Basel, Switzerland), volume 15, issue 7, article 882
Dates: received 28 May 2026; accepted 14 July 2026; published online 16 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/antiox15070882 · PMID 42510613 · PMCID PMC13406045 · OpenAlex W7168772981
Open access: gold, a free copy (OpenAlex)
Categories: mouse (organism), Parkinson's (population), clinical / translational (subfield)
Methods: Spectral & time-frequency, Statistics, Machine learning, Smoothing, state filtering, decompositions
Keywords: Parkinson’s disease, gut microbiota, Lactobacillus reuteri DSM 17938, microbial tryptophan metabolites, probiotics
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Major Science and Technology Plan Special Project in Yunnan Province, China (CB22144SO29A)
Citations: not cited yet (Europe PMC); 54 references in the paper

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder associated with gut dysbiosis and tryptophan metabolism disturbance, but the mechanisms of probiotic action are unclear. We orally administered Lactobacillus reuteri DSM 17938 live bacteria (1.0 × 109 CFU/mL, 0.2 mL) or its fermentation supernatant lyophilized powder at three concentrations to MPTP-induced PD male C57BL/6J mice. Treatments increased locomotor distance and speed, elevated serum SOD and GSH, reduced MDA, TNF-α, IL-6, and IL-1β, promoted neuronal survival, and tended to increase TH expression in the substantia nigra. 16S rRNA sequencing showed that treatments altered gut microbiota composition. PD mice had increased Lactobacillus and Allobaculum but decreased Oscillospira and Helicobacter; treatments restored Oscillospira. Fecal untargeted metabolomics revealed disturbed tryptophan metabolism in PD, with elevated indoleacetic acid and reduced kynurenic acid, xanthurenic acid, indole-3-ethanol, and α-oxo-1H-indole-3-propanoic acid. Treatments significantly restored neuroprotective metabolites including kynurenic acid, xanthurenic acid, and serotonin. PICRUSt2 predicted tryptophan synthesis pathway-associated microbes (Oscillospira, Ruminococcus, Coprococcus). Treatments ameliorated motor deficits, oxidative stress, inflammation, and dopaminergic neuron death, correlating with gut microbiota modulation and accumulation of microbiota-derived tryptophan metabolites. Live bacteria showed superior antioxidant and neuroprotective efficacy compared to supernatant, likely due to sustained colonization and continuous metabolic activity. These findings suggest that targeting key tryptophan-metabolizing bacteria or their metabolites may be a potential PD therapy.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The raw data of 16S rRNA high-throughput sequencing was uploaded to the Sequence Read Archive (SRA) database of NCBI, accession number: PRJNA1345351 (https://www.ncbi.nlm.nih.gov/sra/PRJNA1345351, accessed on 15 July 2026), and the raw data of the untargeted metabolomics has been uploaded to the Metabolights database, accession number: MTBLS13169 (https://www.ebi.ac.uk/metabolights/MTBLS13169, accessed on 15 July 2026). The remaining data are available upon request from the corresponding author or the first author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 5 keywords, 1 funder, 54 references.

Cite

This paper

Su, B., Meng, F., Lu, Y., Zhang, Y., Wang, T., Zhang, Y., Liu, J., & Lin, L. (2026). <i>Lactobacillus reuteri</i> DSM 17938 and Its Supernatant Ameliorate Parkinson's Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism. Antioxidants (Basel, Switzerland), 15(7), 882. https://doi.org/10.3390/antiox15070882

BibTeX

@article{su2026lt,
author = {Su, Bin and Meng, Fanying and Lu, Yao and Zhang, Yunlong and Wang, Tingting and Zhang, Yuxin and Liu, Jiajia and Lin, Lianbing},
title = {{\<i\>Lactobacillus reuteri\</i\> DSM 17938 and Its Supernatant Ameliorate Parkinson's Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism}},
journal = {Antioxidants (Basel, Switzerland)},
year = {2026},
month = jul,
volume = {15},
number = {7},
pages = {882},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2076-3921},
doi = {10.3390/antiox15070882},
url = {https://doi.org/10.3390/antiox15070882},
pmid = {42510613},
pmcid = {PMC13406045}
}

RIS

TY - JOUR
AU - Su, Bin
AU - Meng, Fanying
AU - Lu, Yao
AU - Zhang, Yunlong
AU - Wang, Tingting
AU - Zhang, Yuxin
AU - Liu, Jiajia
AU - Lin, Lianbing
TI - <i>Lactobacillus reuteri</i> DSM 17938 and Its Supernatant Ameliorate Parkinson's Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism
T2 - Antioxidants (Basel, Switzerland)
J2 - Antioxidants (Basel)
PY - 2026
DA - 2026/07/16
VL - 15
IS - 7
SP - 882
SN - 2076-3921
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/antiox15070882
UR - https://doi.org/10.3390/antiox15070882
LA - en
ER -

CSL-JSON

{
"id": "10.3390/antiox15070882",
"type": "article-journal",
"title": "<i>Lactobacillus reuteri</i> DSM 17938 and Its Supernatant Ameliorate Parkinson's Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism",
"container-title": "Antioxidants (Basel, Switzerland)",
"author": [
{
"family": "Su",
"given": "Bin"
},
{
"family": "Meng",
"given": "Fanying"
},
{
"family": "Lu",
"given": "Yao"
},
{
"family": "Zhang",
"given": "Yunlong"
},
{
"family": "Wang",
"given": "Tingting"
},
{
"family": "Zhang",
"given": "Yuxin"
},
{
"family": "Liu",
"given": "Jiajia"
},
{
"family": "Lin",
"given": "Lianbing"
}
],
"container-title-short": "Antioxidants (Basel)",
"volume": "15",
"issue": "7",
"page": "882",
"DOI": "10.3390/antiox15070882",
"PMID": "42510613",
"PMCID": "PMC13406045",
"ISSN": "2076-3921",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/antiox15070882",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
16
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-025-56829-3 [code]
Machine learning-based meta-analysis reveals gut microbiome alterations associated with Parkinson's disease.
Journal: Nature communications
In common: Parkinson's, clinical / translational, 4 references
[2] doi:10.1002/alz.70406 [code]
Synbiotics of Lactobacillus suilingensis and inulin alleviates cognitive impairment via regulating gut microbiota indole-3-lactic acid metabolism in female AD mice.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: mouse, 4 references
[3] doi:10.1021/acschemneuro.3c00127
Gut Microbiome-Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders.
Journal: ACS chemical neuroscience
In common: 5 references
[4] doi:10.3389/fmicb.2023.1094071 [code]
Influence of mental health medication on microbiota in the elderly population in the Valencian region.
Journal: Frontiers in microbiology
In common: 5 references
[5] doi:10.1038/s41531-025-00950-z
Proinflammatory and GABA eating bacteria in Parkinson's disease gut microbiome from a meta-analysis prospective.
Journal: NPJ Parkinson's disease
In common: Parkinson's, clinical / translational, 3 references
[6] doi:10.3389/fnins.2025.1702912
Electroacupuncture exerts neuroprotective effects and alters gut microbiota in a MPTP-induced mouse model of Parkinson's disease.
Journal: Frontiers in neuroscience
In common: Parkinson's, clinical / translational, mouse, 3 references
[7] doi:10.3389/fmicb.2026.1849097 [code]
Gut microbiota dysbiosis in adolescent depression: a comparative analysis with adult depression and healthy adolescent.
Journal: Frontiers in microbiology
In common: 4 references
[8] doi:10.3390/microorganisms10061081 [code]
The Microbiota-Gut-Brain Axis: Gut Microbiota Modulates Conspecific Aggression in Diversely Selected Laying Hens.
Journal: Microorganisms
In common: 4 references
[9] doi:10.1038/s41467-025-67021-y [code]
Histone deacetylase SIRT6 regulates tryptophan catabolism and prevents metabolite imbalance associated with neurodegeneration.
Journal: Nature communications
In common: mouse, 3 references
[10] doi:10.1093/hmg/ddag024 [code]
A microbiome quantitative trait locus in SLC39A8 modulates disease severity in synucleinopathy-induced models of Parkinson's disease.
Journal: Human molecular genetics
In common: Parkinson's, mouse, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.